📣 Help Shape the Future of UKRI's Gateway to Research (GtR)

We're improving UKRI's Gateway to Research and are seeking your input! If you would be interested in being interviewed about the improvements we're making and to have your say about how we can make GtR more user-friendly, impactful, and effective for the Research and Innovation community, please email gateway@ukri.org.

The small molecule inhibitor YK-4-279 disrupts mitotic progression of neuroblastoma cells, overcomes drug resistance and synergizes with inhibitors of mitosis. (2017)

First Author: Kollareddy M

Attributed to: Understanding and targeting chromatin-surveillance mechanisms in human ageing funded by MRC

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1016/j.canlet.2017.05.027

PubMed Identifier: 28602975

Publication URI: http://europepmc.org/abstract/MED/28602975

Type: Journal Article/Review

Volume: 403

Parent Publication: Cancer letters

ISSN: 0304-3835